Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and ...

The FDA is moving to scale back its long-standing use of expert panels to review drug applications, KFF Health News reported Sept. 12. George Tidmarsh, MD, PhD, director of the FDA’s Center for Drug ...

He relayed the message Tuesday at a meeting of health care product makers and Wednesday to an FDA advocacy group. In addition ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s top drug regulator, the agency confirmed Monday. Tidmarsh, an adjunct ...

The FDA is planning to call on the health-care industry and consumers to provide information on the benefits of switching a prescription drug to over-the-counter, the agency’s drug chief said Tuesday.

(Reuters) -The U.S. Food and Drug Administration said on Monday it has appointed George Tidmarsh, a seasoned biotech executive and longtime Stanford University professor, as the director of the Center ...

The Food and Drug Administration on Monday announced George Tidmarsh as director of its Center for Drug Evaluation and Research. File Photo by Jim Lo Scalzo/EPA-EFE July 21 (UPI) --The U.S. Food and ...

The Food and Drug Administration said Monday it has appointed former biotech executive George Tidmarsh as the agency's top drug regulator. Tidmarsh, an adjunct professor of pediatrics and neonatology ...

The Food and Drug Administration on Monday name George Tidmarsh, a longtime biotech executive who has a background in oncology and pediatrics, its top drug regulator. Tidmarsh, who will be the ...

Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on rebalancing inflammation to optimize health, announced the ...